Literature DB >> 647301

Intermittent claudication: prevalence and risk factors.

W G Hughson, J I Mann, A Garrod.   

Abstract

Risk factors for intermittent claudication (IC) were studied in 54 patients--that is, all patients with IC on the lists of two general practices--and 108 controls. Smoking was the factor most strongly associated with the development of IC, but systolic and diastolic blood pressures and concentrations of triglyceride, urate, and fibrinogen were all significantly higher among the patients with IC than the controls. The presence of more than one factor appeared to be associated with a multiplicative increase in risk. Cholesterol, an important risk factor for ischaemic heart disease, was not associated with an increased risk of IC. IC was present in about 2% of the men and 1% of the women, who were aged 45-69 years. These findings suggest that IC, a common and disabling manifestation of atheroslcerosis, may be largely preventable.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 647301      PMCID: PMC1604804          DOI: 10.1136/bmj.1.6124.1379

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  13 in total

1.  Statistical aspects of the analysis of data from retrospective studies of disease.

Authors:  N MANTEL; W HAENSZEL
Journal:  J Natl Cancer Inst       Date:  1959-04       Impact factor: 13.506

2.  Arteriosclerosis obliterans: review of 520 cases with special reference to pathogenic and prognostic factors.

Authors:  J L JUERGENS; N W BARKER; E A HINES
Journal:  Circulation       Date:  1960-02       Impact factor: 29.690

3.  A new method for the determination of fibrinogen in small samples of plasma.

Authors:  O D RATNOFF; C MENZIE
Journal:  J Lab Clin Med       Date:  1951-02

4.  Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population.

Authors:  B Lewis; A Chait; C M Oakley; I D Wootton; D M Krikler; A Onitiri; G Sigurdsson; A February
Journal:  Br Med J       Date:  1974-08-24

5.  Serum lipids and lipoproteins in peripheral vascular disease.

Authors:  R M Greenhalgh; D S Rosengarten; I Mervart; B Lewis; J S Calnan; P Martin
Journal:  Lancet       Date:  1971-10-30       Impact factor: 79.321

6.  Predisposition to atherosclerosis in the head, heart, and legs. The Framingham study.

Authors:  T Gordon; W B Kannel
Journal:  JAMA       Date:  1972-08-14       Impact factor: 56.272

7.  The fluorometric assay of triglyceride by a semiautomated method.

Authors:  D G Cramp; G Robertson
Journal:  Anal Biochem       Date:  1968-10-24       Impact factor: 3.365

8.  Gout and cardiovascular disease.

Authors:  P D Winocour; M R Turner; T G Taylor; K A Munday
Journal:  Lancet       Date:  1977-04-30       Impact factor: 79.321

9.  Blood-sugar and arterial disease.

Authors:  H Keen; G Rose; D A Pyke; D Boyns; C Chlouverakis
Journal:  Lancet       Date:  1965-09-11       Impact factor: 79.321

10.  Viscosity of blood in normal subjects and in patients suffering from coronary occlusion and arterial thrombosis. An in vitro study in the absence of anticoagulants, by means of a rotational cone-in-cone trolley viscometer.

Authors:  L Dintenfass; D G Julian; G E Miller
Journal:  Am Heart J       Date:  1966-05       Impact factor: 4.749

View more
  24 in total

Review 1.  Current strategies in the diagnosis and management of lower extremity peripheral vascular disease.

Authors:  T J Wilt
Journal:  J Gen Intern Med       Date:  1992 Jan-Feb       Impact factor: 5.128

2.  Fate in intermittent claudication: outcome and risk factors.

Authors:  R Jelnes; O Gaardsting; K Hougaard Jensen; N Baekgaard; K H Tønnesen; T Schroeder
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-01

3.  Variability of ankle and brachial systolic pressures in the measurement of atherosclerotic peripheral arterial disease.

Authors:  F G Fowkes; E Housley; C C Macintyre; R J Prescott; C V Ruckley
Journal:  J Epidemiol Community Health       Date:  1988-06       Impact factor: 3.710

Review 4.  Aetiology of peripheral atherosclerosis.

Authors:  F G Fowkes
Journal:  BMJ       Date:  1989-02-18

Review 5.  Review of general surgery 1978.

Authors:  H Ellis
Journal:  Postgrad Med J       Date:  1979       Impact factor: 2.401

6.  Current therapy for intermittent claudication.

Authors:  M Verstraete
Journal:  Drugs       Date:  1982-09       Impact factor: 9.546

7.  Large vessel occlusive disease associated with CREST syndrome and scleroderma.

Authors:  P Youssef; H Englert; J Bertouch
Journal:  Ann Rheum Dis       Date:  1993-06       Impact factor: 19.103

Review 8.  Endovascular stents for intermittent claudication.

Authors:  Paul Bachoo; P A Thorpe; Heather Maxwell; Karen Welch
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

9.  Smoking as a crucial independent determinant of stroke.

Authors:  Seana L Paul; Amanda G Thrift; Geoffrey A Donnan
Journal:  Tob Induc Dis       Date:  2004-06-15       Impact factor: 2.600

10.  Long-term survival after initial hospital admission for peripheral arterial disease in the lower extremities.

Authors:  I Vaartjes; G J de Borst; J B Reitsma; A de Bruin; F L Moll; D E Grobbee; M L Bots
Journal:  BMC Cardiovasc Disord       Date:  2009-08-28       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.